cas 1199767-11-7|| where to buy 5-(p-Tolyl)-1,2,4-triazin-3(2H)-one

Nom du produit:5-(p-Tolyl)-1,2,4-triazin-3(2H)-one

IUPAC Name:5-(4-methylphenyl)-2,3-dihydro-1,2,4-triazin-3-one

Unité d'emballage	Stock disponible	Prix($)	Quantité
CM488621-1g	in stock	ŭȋƏƻ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1199767-11-7 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1199767-11-7; Formule moléculaire:C10H9N3O; Point de fusion:-; Code SMILES:O=C1NN=CC(C2=CC=C(C)C=C2)=N1; Densité:

: Numéro de catalogue:CM488621; Poids moléculaire:187.2; Point d'ébullition:; N° Mdl:; Stockage:Sealed in dry,Room Temperature

: Triazines; Triazines are an important class of six-membered aromatic heterocycles with three nitrogen atoms that give rise to three regioisomers: 1,2,4-triazines, 1,2,3-triazines, and 1,3, 5-triazine. 1,2,3-Triazines show remarkable reactivity and have attracted attention for their medicinal value. Triazine compounds fused with other carbon and heterocycles are stable and have a broad spectrum of pharmacological activities.

: Lorundrostat; Mineralys Therapeutics announced that the first subject has been dosed in the Launch-HTN pivotal trial to evaluate the safety and efficacy of lorundrostat for the treatment of uncontrolled hypertension (uHTN) or resistant hypertension (rHTN), when used as an add-on therapy to prescribed background treatment. Lorundrostat is a proprietary, orally administered, highly selective aldosterone synthase inhibitor being developed for the treatment of uncontrolled and resistant hypertension and CKD. Lorundrostat was designed to reduce aldosterone levels by inhibiting CYP11B2, the enzyme responsible for its production.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.